Abstract:Introduction: NAA10-related syndrome is characterized by long QT syndrome (LQTS), cardiomyopathy, hypotonia, and neurodevelopmental delay. NAA10 complexes with the regulatory subunit NAA15 to make the post-translationally modifying N-terminal acetyltransferase, NatA. Despite the association of LQTS and NAA10 mutations, the mechanism is unknown. Hypothesis: NAA10 dysfunction affects the function of cardiac ion channels or related proteins causing LQTS, and sarcomere abnormalities causing cardiomyopathy. Methods: Target sequencing of large kindred with multiple family members who had LQTS and sudden death revealed a segregating mutation in NAA10 (c.10C>A; p.R4S). Somatic cell reprogramming was used to create an induced pluripotent stem cell (iPSC) line from a gene-positive male patient with LQTS and dilated cardiomyopathy (pNAA10 R4S ). Genome-editing was used to create the control iPSC line (eNAA10 R4S ). iPSC lines were differentiated into cardiomyocytes (iPSC-CMs) for further analysis. In addition, we performed biochemical assays to investigate the enzymatic activities of the NAA10-R4S mutation. Results: The NAA10-R4S mutation had reduced enzymatic activity, decreased expression levels of NAA10/NAA15 and destabilized the NatA complex. Action potential duration was prolonged in pNAA10 R4S - and eNAA10 R4S -iPSC-CMs as compared to WT iPSC-CMs (498.9 ± 38.8 ms and 514.1 ± 52.9 ms, vs 316.7 ± 48.2 ms; p<0.05). Investigation of the underlying ion channel currents revealed increased late I Na (Late I Na / Peak I Na : pNAA10 R4S : 0.062 ± 0.010 % and eNAA10 R4S : 0.074 ± 0.020 % vs. WT: 0.026 ± 0.005 %; p<0.05) and reduced I Ks (pNAA10 R4S : 0.18 ± 0.05 pA/pF and eNAA10 R4S : 0.26 ± 0.04 pA/pF vs. WT: 0.61 ± 0.15 pA/pF; p<0.05). There were no significant differences in I Kr and I CaL . Diastolic Ca 2+ levels were increased in mutant iPSC-CMs (F340/F380: 0.18 ± 0.02 vs 0.04 ± 0.01; p<0.05) consistent with impaired Ca 2+ handling. Plating iPSC-CMs on micro-contact printed islands revealed alterations in sarcomeric structure. Conclusion: We demonstrate that the NAA10 mutation cause abnormalities in ion channels and sarcomere development. Our data indicated a novel role for N-terminal acetylation in cardiac ion channel regulation leading to cardiovascular disorders.

Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.

Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome

Identification and Functional Characterization of a Novel CACNA1C -Mediated Cardiac Disorder Characterized by Prolonged QT Intervals with Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death

Genome Editing of Isogenic Human Induced Pluripotent Stem Cells Recapitulates Long QT Phenotype for Drug Testing.

A Pore-Localizing CACNA1C-E1115K Missense Mutation, Identified in a Patient with Idiopathic QT Prolongation, Bradycardia, and Autism Spectrum Disorder, Converts the L-type Calcium Channel into a Hybrid Nonselective Monovalent Cation Channel.

Abstract 9741: A Novel Mutation Identified in a Large Multi-Generational Family With Long QT Syndrome Reveals Distinct, Disease-Specific Mutation Hot Spots within the <i>CACNA1C-</i> Encoded L-type Calcium Channel

Computational Cardiac Modeling Reveals Mechanisms of Ventricular Arrhythmogenesis in Long QT Syndrome Type 8: CACNA1C R858H Mutation Linked to Ventricular Fibrillation

Α-1-syntrophin Mutation and the Long-QT Syndrome

Novel long QT syndrome-associated missense mutation, L762F, in CACNA1C-encoded L-type calcium channel imparts a slower inactivation tau and increased sustained and window current

Discovery and Characterization of a Monogenetic Insult, Caveolin-3-v37l, That Precipitated Oligo-Proteomic Perturbations Governing Repolarization Reserve.

A mutation in the CACNA1C gene leads to early repolarization syndrome with incomplete penetrance: A Chinese family study

Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome.

Clinical Aspects of Type-1 Long-Qt Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene.

Mechanisms by Which SCN5A Mutation N1325S Causes Cardiac Arrhythmias and Sudden Death in Vivo.

In Silico Investigation of CACNA2D1 S755T Mutation Associated with Short QT Syndrome

In Silico Investigation of the CACNA1C N2091S Mutation in Timothy Syndrome.

Defining Cardiomyocyte Repolarization Response to Pharmacotherapy in Long-QT Syndrome Type 3

Abstract P1037: Dysfunction Of N-terminal Acetylation Causes Multiple Electrical Abnormalities Leading To Long QT Syndrome And Dilated Cardiomyopathy

Pro-Arrhythmogenic Effects of Cacna1c G1911r Mutation in Human Ventricular Tachycardia: Insights from Cardiac Multi-Scale Models

Patient-specific Induced Pluripotent Stem Cell Properties Implicate Ca2+-homeostasis in Clinical Arrhythmia Associated with Combined Heterozygous RYR2 and SCN10A Variants.

Development of a Patient-Specific P.d85n-Potassium Voltage-Gated Channel Subfamily E Member 1–induced Pluripotent Stem Cell–Derived Cardiomyocyte Model for Drug-Induced Long QT Syndrome